MIT develops a new vaccine offering protection against SARS-CoV-2 variants and related sarbecoviruses, addressing future pandemic threats.

Trump’s nominees have big plans for remaking the federal health agencies, with consequences for university scientists who receive billions in funding.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Outbreaks in commercial poultry have recently been reported in a tri-state area that makes up the Delmarva peninsula, and regional officials are collaborating on a unified response ...

Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long ...

Measles is surging and vaccine hesitancy is up. In his book "Booster Shots," Dr Adam Ratner explains why measles is back and how we can control this deadly infectious killer.

In a crowded Paris metro car or at the counter of a bustling café, it’s easy to forget what loomed over us just five years ago.Yet, on the fifth anniversary of the first Covid-19 lockdown in Wuhan, ...

So far, 59 people in Pune have been diagnosed with Guillain-Barré Syndrome (GBS), a rare neurological disorder. Authorities have yet to identify the cause of the outbreak. However, rumours have been ...

Global Health was first included on the G20 agenda in 2017, during Germany’s Presidency, to underscore the political support ...

Norovirus levels in hospitals in England are 80% higher than the same period last year, new figures show today as pressure on NHS services remains high.  New data published today shows that 784 ...

HuffPost spoke with medical experts and researchers about vaccine facts that everyone should know, and why staying up to date ...